Updated 7 days ago
Sodium Citrate Blood Collection Tube Manufacturer for Coagulation Labs
trustlabofficial
Sodium citrate blood collection tubes in a coagulation laboratory rack
A sodium citrate blood collection tube manufacturer should provide more than a product name or blue cap. Coagulation laboratories and distributors need to confirm the exact citrate formulation, blood-to-additive ratio, tube configuration, intended use, handling instructions, and supporting documentation before approving a supplier.
Trustlab’s website identifies a sodium citrate tube product page associated with coagulation testing. However, product-specific details such as model or SKU, material, draw volume, sterility, regulatory status, and manufacturing arrangement should be confirmed through the current product page and technical documents before procurement.
What a Coagulation Laboratory Should Expect from a Sodium Citrate Tube Manufacturer
A qualified supplier should be able to identify the exact product being offered and provide documentation that allows the buyer to assess technical and regulatory suitability.
Before approval, request information covering:
- Sodium citrate concentration
- Blood-to-additive ratio
- Nominal draw volume
- Tube material
- Tube dimensions and closure
- Vacuum or non-vacuum format
- Packaging quantity and labeling
- Storage conditions and shelf life, where applicable
- Intended use and handling instructions
- Current technical data sheet (TDS)
- Instructions for use (IFU)
- Applicable quality-management and regulatory documentation
- Sample availability for laboratory evaluation, if offered
These details should remain attached to the relevant product model or SKU. A general category description should not be used to fill gaps in an exact product specification.
For broader supplier-evaluation criteria, see how to evaluate blood collection system supplier quality.
Product Specification Fields to Confirm Before Approval
| Specification or document | Why the buyer needs it | Evidence to request |
|---|---|---|
| Citrate concentration | Confirms the formulation being supplied | Current TDS or product specification |
| Blood-to-additive ratio | Helps assess the intended specimen-to-additive relationship | TDS, IFU, or applicable technical documentation |
| Nominal draw volume | Supports workflow and collection planning | Exact model/SKU specification |
| Tube material | May affect handling, transport, and equipment fit | Product specification or material declaration |
| Tube dimensions | Helps confirm rack, carrier, and workflow fit | Dimensional drawing or TDS |
| Closure and cap | Supports identification and handling | Product documentation |
| Vacuum or non-vacuum format | Confirms the collection method | Product page, TDS, or IFU |
| Packaging and labeling | Supports inventory control and market requirements | Packaging specification |
| Storage and shelf life | Supports purchasing and stock management | IFU, label, or shelf-life document |
| Intended use | Defines the product’s documented application | IFU or regulatory documentation |
Do not assume that a product listed under a blood collection category is manufactured in-house by the website owner. Trustlab’s manufacturing or distribution role for this specific product should be confirmed directly.
Documentation Is Part of the Product Qualification
A supplier’s documentation package should be evaluated alongside the physical tube. A TDS may provide technical specifications, while an IFU should define the documented intended use, handling instructions, limitations, and storage requirements for the specific product.
Quality certificates require equally careful interpretation. An ISO 13485 or ISO 9001 certificate applies to the quality-management system and the scope stated on the certificate. It does not automatically prove that every listed product is CE-marked, FDA-cleared, sterile, clinically validated, or registered in every market.
Ask the supplier to identify:
- The legal entity named on each certificate
- Certificate scope and validity
- Product or model covered by regulatory documentation
- Destination-market requirements
- Document revision or issue date
- Whether the evidence applies to the exact product, a product family, or the company’s management system
Sodium Citrate Tube Configurations Relevant to Coagulation Workflows
The most important configuration factors are citrate concentration, blood-to-additive ratio, tube material, draw volume, dimensions, closure, and collection format.
Market examples commonly include 3.2% sodium citrate tubes and a 1:9 blood-to-additive ratio, but a competitor’s specification should not be transferred to Trustlab or treated as proof of a universal requirement. For example, BOENMED publishes 3.2% citrate configurations with a 1:9 ratio and different materials and draw volumes on its product page, while Greiner Bio-One publishes multiple coagulation-tube variants in its VACUETTE® range:
These pages are useful market references, not evidence of Trustlab’s product specifications.
Citrate Concentration and Blood-to-Additive Ratio
Sodium citrate is used as an anticoagulant for coagulation specimen collection. The concentration and the volume of blood relative to the additive are separate product attributes.
A buyer should therefore confirm both:
- The stated citrate concentration, such as 3.2% or another documented formulation.
- The intended blood-to-additive relationship at the specified draw volume.
Underfilling can change the intended specimen-to-additive relationship. That is why collection, mixing, transport, and specimen-acceptance procedures should follow the applicable IFU and laboratory policy rather than a generic instruction copied from another supplier.
A 3.2% tube should not automatically be described as suitable for every coagulation application. The laboratory should match the product documentation to its testing workflow and local requirements.
Material, Volume, Dimensions, and Collection Format
A buyer may also need to compare PET and glass configurations, evacuated and non-evacuated formats, tube dimensions, closure systems, and nominal draw volumes.
These attributes should be reviewed separately:
- Material is not the same as tube capacity.
- Nominal draw volume is not the same as external dimensions.
- Vacuum format does not prove compatibility with every collection system.
- Package quantity is not the same as the number of specimens a tube can collect.
- A product category does not establish the specifications of every model within that category.
For an overview of tube-format differences, see different types of vacuum blood collection tubes. General vacuum-collection context is available in vacuum blood collection tubes.
Coagulation-Laboratory Applications and Pre-Analytical Limits
Sodium citrate tubes are commonly associated with coagulation specimen workflows, including testing contexts such as prothrombin time (PT), activated partial thromboplastin time (aPTT), and INR-related reporting. The tube itself does not guarantee analytical performance. Suitability depends on the exact product, the specimen collection process, the laboratory method, and the applicable instructions.
Important pre-analytical factors include:
| Factor | Why it matters | What to confirm |
|---|---|---|
| Correct tube type | Ensures the additive matches the intended workflow | Product label and IFU |
| Adequate fill | Maintains the intended blood-to-additive relationship | Draw-volume specification and laboratory procedure |
| Mixing | Helps distribute the additive through the specimen | Exact IFU instructions |
| Transport and storage | May affect specimen condition before testing | IFU and laboratory policy |
| Test method | Different methods may have specific requirements | Laboratory validation and applicable guidance |
| Product substitution | A different tube may not behave identically | Verification before routine use |
A CTAD tube should also be treated as a distinct hemostasis collection product rather than as a synonym for every sodium citrate tube. The U.S. FDA describes a Vacutainer evacuated blood collection system for the collection and transport of hemostasis specimens, including CTAD-related use, in product-specific documentation: FDA Vacutainer Evacuated Blood Collection System.
Underfilling, Mixing, and Handling Questions
Underfilling a sodium citrate tube can alter the intended proportion between blood and additive. The appropriate response depends on the product instructions, laboratory acceptance criteria, and the relevant testing procedure.
For this reason:
- Follow the exact IFU for the selected product.
- Do not apply an inversion count from another manufacturer without checking the applicable instructions.
- Do not assume that a correctly colored cap confirms correct fill or specimen suitability.
- Record any supplier or tube change in the laboratory’s verification process.
- Confirm transport and storage requirements before routine implementation.
The published guidance on alternative sodium citrate coagulation tubes emphasizes the need to evaluate replacement sources rather than assuming that different commercial tubes are automatically interchangeable: Guidance on the critical shortage of sodium citrate coagulation tubes for hemostasis testing.
How to Qualify a Sodium Citrate Tube Manufacturer
A practical qualification process can help a laboratory compare suppliers consistently.
- Define the laboratory requirement.
Specify the intended coagulation workflow, target market, collection method, required citrate concentration, blood-to-additive ratio, nominal volume, material, and physical format.
- Request the exact product identity.
Ask for the product name, model number, catalog code, SKU, variant, and package quantity. Do not approve a category description when the supplier can provide a more specific identifier.
- Compare the technical specification.
Review concentration, ratio, volume, dimensions, material, closure, vacuum status, packaging, storage, and shelf life against the laboratory’s requirements.
- Review the evidence package.
Request the current TDS, IFU, certificates, regulatory or conformity documents, and any applicable product-specific reports.
- Separate QMS evidence from product evidence.
An ISO 9001 or ISO 13485 certificate may support confidence in the stated quality-management scope, but it does not by itself establish product-level regulatory status or clinical performance.
- Evaluate samples when appropriate.
If samples are supplied, define the laboratory’s evaluation criteria before testing. Keep sample observations separate from certified product specifications.
- Complete verification before routine adoption.
A supplier change may require laboratory verification or validation appropriate to the workflow. Document the decision, the product identity, the evidence reviewed, and any acceptance criteria.
Documents to Request from the Supplier
A buyer can request the following documentation package:
- Current product catalog or product-page reference
- Exact model/SKU and product code
- Technical data sheet
- Instructions for use
- Material, dimension, draw-volume, and packaging information
- Storage and shelf-life information
- Quality-management certificates with scope and validity
- Product-specific regulatory or conformity documents for the destination market
- Sample information and lot details, if samples are available
- Change-notification or revision information where applicable
A document should be assessed for what it actually proves. For example, a QMS certificate can support a management-system claim within its stated scope; it should not be rewritten as automatic proof of CE marking, FDA status, sterility, or product performance.
Questions to Include in a Quotation or Sample Request
A technical inquiry should give the supplier enough information to identify the appropriate configuration. Include:
- Intended use and coagulation workflow
- Required citrate concentration
- Required blood-to-additive ratio
- Nominal draw volume
- Preferred material
- Tube dimensions and closure requirements
- Vacuum or non-vacuum format
- Packaging and labeling needs
- Destination market
- Required TDS, IFU, certificates, and regulatory documents
- Sample-evaluation requirements
- Any MOQ, lead-time, OEM, or customization questions that require confirmation
These are questions for supplier confirmation, not assumptions about Trustlab’s commercial capabilities.
Trustlab Sodium Citrate Tube Information to Confirm
Trustlab’s website includes a product URL titled “Sodium Citrate Tube – 3.2% Anticoagulant for Coagulation Tests”: Trustlab sodium citrate tube product page.
The page title indicates a sodium citrate product associated with coagulation testing, but the available research did not verify the complete product specification or the company’s manufacturing arrangement for that exact item. Before using Trustlab as an approved supplier, request confirmation of the following:
| Information to confirm | Why confirmation is needed |
|---|---|
| Exact product model or SKU | Prevents category-level information being mistaken for a specific product |
| Citrate concentration and formulation | Confirms the additive specification |
| Blood-to-additive ratio | Confirms the intended collection relationship |
| Material and dimensions | Supports workflow and equipment fit |
| Nominal draw volume | Supports specimen-collection requirements |
| Vacuum or non-vacuum format | Confirms the collection method |
| Sterile or non-sterile status | Requires exact product and packaging evidence |
| Storage and shelf life | Supports inventory and handling decisions |
| IFU and TDS | Defines intended use, handling, and specifications |
| Regulatory documentation | Must match the product and destination market |
| QMS certificate scope | Shows what the certificate actually covers |
| Manufacturing or supply arrangement | Confirms whether Trustlab manufactures, distributes, or sources the product |
Do not infer product certification, sterility, clinical performance, in-house manufacturing, or analyzer compatibility from the product listing alone. Likewise, broad Trustlab website language about CE or ISO should not be treated as proof of product-level approval.
Claims That Require Product-Specific Confirmation
The following claims should remain unpublished unless the relevant evidence is available for the exact product or model:
- CE marking or other market-specific conformity status
- FDA clearance, approval, registration, or listing
- ISO 9001 or ISO 13485 certificate scope as it applies to the supplier
- Sterile or non-sterile status
- Specific material, dimensions, draw volume, or package quantity
- Shelf life and storage conditions
- Accuracy, precision, stability, or sample-quality performance
- Compatibility with a particular analyzer, rack, needle, or collection system
- OEM, private-label, MOQ, sample, pricing, or lead-time availability
A listed sodium citrate tube confirms that the product topic exists within the site architecture. It does not, by itself, verify every technical or commercial attribute a buyer may require.
Request a Product Review, Sample, or Quotation
For a technical review, provide Trustlab with the laboratory’s required citrate concentration, blood-to-additive ratio, nominal draw volume, material, tube format, destination market, and documentation requirements.
A supplier discussion should identify the exact product or SKU and provide the current TDS, IFU, packaging information, and applicable quality or regulatory documents. If samples or quotations are available, they should be evaluated against the same requirements used for supplier approval.
This approach helps coagulation laboratories compare sodium citrate blood collection tube manufacturers on documented suitability rather than on general claims such as “high quality,” “safe,” or “reliable.”
